Company Overview
| Stock Name | Yestar Health |
|---|---|
| Stock Code | 02393 |
| Company Full Name | To be extracted |
| Industry | Industrial Goods |
| Principal Activities | 中國領先的彩色相紙供應商之一,亦是多種影像產品的供應商,通過分切及縱切將彩色相紙大軸剪裁成訂製尺寸,加工即用型彩色相紙、多種影像打印膠片及醫學影像膠片;並為富士膠片彩色相紙及彩色膠片在中國最大的授權經銷商及加工商。 |
| Listing Date | 2013-10-11 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海閔行區莘建東路58號2棟805室 |
| Business Address (Hong Kong) | 香港灣仔告士打道109-111號東惠商業大廈2403室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.yestarcorp.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 1.38 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2013-09-27 to 2013-10-03 |
| Global Offering Shares | 112,500,000 shares |
| HK Public Offer Shares (Initial) | 11,250,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 101,250,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 450,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 155,250,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 167.4M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +5704% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 598,500,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利约人民币58.0百万元 |
| Period-End Cash Balance | 人民币160.4百万元 |
| Listing Expenses | ~HK$ 47,200,000 |
| Listing Expenses / Funds Raised | ~30.4% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2010 | 2011 | 2012 | 2013-05 |
|---|---|---|---|---|
| Revenue | 523,177 | 977,098 | 955,818 | 414,024 |
| Cost of sales | -437,873 | -813,679 | -788,508 | -340,354 |
| Gross profit | 85,304 | 163,419 | 167,310 | 73,670 |
| Other income and gains, net | 8,184 | 10,834 | 8,468 | 2,444 |
| Selling and distribution expenses | -38,464 | -55,777 | -49,638 | -21,266 |
| Administrative expenses | -24,694 | -41,465 | -41,101 | -21,866 |
| Operating profit | 29,794 | 72,865 | 84,448 | 32,656 |
| Net finance costs | -2,603 | -3,562 | -2,875 | -1,739 |
| Profit before tax | 27,191 | 69,303 | 81,573 | 30,917 |
| Income tax expense | -5,515 | -21,008 | -23,540 | -10,797 |
| Profit for the year | 21,676 | 48,295 | 58,033 | 20,120 |
| Profit attributable to owners | 19,297 | 47,312 | 56,517 | 20,281 |
Balance Sheet
| Item | 2010 | 2011 | 2012 | 2013-05 |
|---|---|---|---|---|
| Cash and cash equivalents | 68,537 | 142,039 | 160,393 | 135,204 |
| Trade and bills receivables | 11,826 | 36,941 | 100,754 | 117,360 |
| Inventories | 143,093 | 132,827 | 177,768 | 228,707 |
| Total current assets | 277,257 | 401,435 | 467,673 | 531,235 |
| Total assets | 339,296 | 475,861 | 587,201 | 664,587 |
| Total current liabilities | 187,039 | 289,145 | 407,937 | 462,992 |
| Total liabilities | 206,004 | 294,274 | 438,098 | 495,364 |
| Total equity | 133,292 | 181,587 | 149,103 | 169,223 |
| Equity attributable to owners | 111,123 | 158,435 | 140,153 | 160,434 |
| Interest-bearing borrowings | 37,000 | 46,600 | 45,000 | 65,000 |
Cash Flow Statement
| Item | 2010 | 2011 | 2012 | 2013-05 |
|---|---|---|---|---|
| Net cash from operating activities | 53,842 | 100,077 | 44,638 | -21,354 |
| Net cash from investing activities | -23,747 | -32,613 | -21,816 | -24,882 |
| Net cash from financing activities | -2,435 | 6,038 | -4,468 | 21,047 |
| Net increase in cash | 27,660 | 73,502 | 18,354 | -25,189 |
| Depreciation of PP&E | 8,932 | 9,382 | 9,316 | 4,852 |
| Amortisation of intangible assets | 464 | 558 | 475 | 214 |
| Purchase of PP&E | -17,908 | -6,893 | -51,883 | -17,717 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 1.58 |
|---|---|
| First Day Open | HK$ 1.61 |
| First Day Change | -1.04% |
| First Day Volume | 35010000.0 |
| First Day Turnover | 55221000.0 |
| Use of Proceeds | 1、約35%所得款項凈額或3770萬港幣將用于購置設備及用作成立全印館網絡的開辦費用; 2、約30%所得款項凈額或3230萬港幣將用作收購一間用于全國銷售網絡、生產能力及在中國從事醫用X射線設備業務所需牌照的醫療設備公司的全部或大部分權益; 3、約15%所得款項凈額或1620萬港幣將用作擴充本公司的加工能力及興建加工設施; 4、約10%所得款項凈額或1080萬港幣將用研發活動; 5、約10%所得款項凈額或1080萬港幣將用公司一般營運資金及其他用途。 |
Underwriting Syndicate
Sole Sponsor (1)
海通国际资本有限公司 CE ADQ859
Overall Coordinators (1)
海通国际证券有限公司 CE AAF806
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 何震發 | — |
| Company Secretary | 高卓安 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Jeane Hartono(37.61%)、何震發(14.75%)、Rico Hartono(14.75%)、Chen Chen Irene Hartono(6.64%);控股股東合共約73.73% |
|---|




